The construction area of the first phase of the Guangxi production base is about 15,000 square meters, and the annual production capacity can reach 30 million head parts, which is the largest in China. At present, it has successfully passed the acceptance of veterinary drug GMP of the Ministry of Agriculture and Rural Affairs, and obtained the "Veterinary drug GMP Certificate" and "Veterinary drug Production License", and is declaring the approval number of veterinary drug.

The project is divided into two phases, the first phase of the project land about 130 acres, the second phase of the project land about 100 acres. Products cover cat triple, dog triple and other pet vaccines, cat triple vaccine is expected to become the first independent research and development and production of cat joint vaccine products, will break the long-term monopoly pattern of foreign animal protection companies in this field. In addition to pet vaccines, the products also include deworming drugs, antiviral drugs and other pet medicines.